Unfortunately, in our experiments, although lymphocytes expanded in IL-21 indeed were enriched for the CD62L+CD44− phenotype, this did not translate into either higher proliferative capacity in vitro nor greater anti-tumor efficacy in vivo. Here, SELL is linked to neoplasm.